Misericordia Community Hospital
Welcome,         Profile    Billing    Logout  
 7 Trials 
15 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kawchuk, Greg N
NCT06347991: Alberta Chiropractic SelfBack Study

Recruiting
N/A
100
Canada
SelfBack
University of Alberta, Chiropractic Association of Alberta
Chronic Low-back Pain
12/24
12/25
Olson, David
PLAN, NCT04874038: Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery

Recruiting
3
1602
Canada
Lidocaine 20mg/ml, Lidocaine 2%, Placebo, 0.9% sodium chloride solution
University Health Network, Toronto, Canadian Institutes of Health Research (CIHR)
Post-mastectomy Pain Syndrome, Breast Cancer, Pain, Postoperative, Pain, Chronic
06/25
06/26
NCT02548559: Sublingual Cannabidiol for Anxiety

Recruiting
2
97
US
Full-Spectrum Cannabidiol, Single-Compound Cannabidiol, Placebo
Staci Gruber, Ph.D.
Anxiety
08/25
08/25
Welsh, Rob
CELEBRATE, NCT04825743: A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Recruiting
3
2499
Europe, Canada, RoW
zalunfiban, RUC-4, Placebo
CeleCor Therapeutics
ST-elevation Myocardial Infarction (STEMI)
12/24
12/24
Rewa, Oleksa G
LIBERATE, NCT04489589: Midodrine for the Early Liberation of Vasopressor Support in the ICU

Completed
4
20
Canada
Midodrine, Midodrine Hydrochloride, Placebo, Microcrystalline cellulose
University of Alberta, Alberta Health services, Institute of Health Economics, Canada
Critical Illness, Shock
07/22
10/22
LIBERATE Multi-Site, NCT05058612: Midodrine for the Early Liberation of Vasopressor Support in the ICU

Recruiting
4
350
Canada
Midodrine, Placebo
University of Alberta, University Hospital Foundation, Institute of Health Economics, Canada, Alberta Health services
Vasoplegia
12/24
03/25
FaST-1, NCT04588792: Furosemide as Supportive Therapy for COVID-19 Respiratory Failure

Terminated
2/3
40
Canada
Nebulized Furosemide, Nebulized Saline
Dr. John Muscedere, University Health Network, Toronto
Covid19, Respiratory Failure
02/23
04/23
REVIVe, NCT05246098: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI

Recruiting
N/A
900
Canada
McMaster University, Canadian Institutes of Health Research (CIHR), Canadian Critical Care Trials Group
Respiratory Disease, COVID-19, Viral Infection
03/25
10/25
QUALITY CRRT, NCT04221932: Implementation of CRRT KPI Reports to Standardize and Improve the Quality of CRRT Delivery in Alberta ""

Recruiting
N/A
1500
Canada
CRRT KPI Reports
University of Alberta, Institute of Health Economics, Canada, Alberta Innovates Health Solutions
Critical Illness, Acute Kidney Failure
12/24
06/25
NCT05186636: Dialyzing Wisely - Improving the Delivery of Acute Renal Replacement Therapy to Albertans

Recruiting
N/A
4500
Canada
KPI reports, Monitoring, reporting and regular review of acute RRT KPIs, Prescriber reports
University of Alberta, Alberta Innovates Health Solutions
Acute Renal Injury
12/24
06/25
ARBS CORONA I, NCT04510623: Host Response Mediators in Coronavirus (COVID-19) Infection

Recruiting
N/A
500
Canada
ARBs and/or ACE inhibitors, Usual Care
University of British Columbia, Canadian Institutes of Health Research (CIHR), British Columbia Centre for Disease Control, McGill University Health Centre/Research Institute of the McGill University Health Centre, University of Toronto, University of Ottawa, University of Calgary, University of Alberta, University of Victoria, Wuhan University, Peking Union Medical College, University of Pennsylvania
COVID-19, SARS-CoV2
06/21
06/22
O'Neil, Conar
CATCO, NCT04330690: Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial

Active, not recruiting
3
2900
Canada
Artesunate, Imatinib, Infliximab, Dexamethasone, LSALT Peptide
Sunnybrook Health Sciences Centre, AbbVie, Apotex Inc., World Health Organization, University of British Columbia, Arch Biopartners Inc.
COVID-19
03/24
05/24
Chen, Justin
PATHFINDER 2, NCT05155605: A Multi-Cancer Early Detection Study

Recruiting
N/A
35000
Canada, US
Multi-Cancer Early Detection Test
GRAIL, LLC
Early Detection of Cancer, Cancer
08/24
12/27
NCT06338176: Optimizing the Management of Staphylococcus Aureus Bacteremia (OPTIMUS-SAB)

Recruiting
N/A
1800
Canada
OPTIMUS-SAB clinical care pathway
University of Alberta, Alberta Health services
Staph Aureus Bacteremia
10/25
04/26
Shibata, Marcelo C
NCT05592275: A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Recruiting
2
456
Europe, Canada, Japan, US, RoW
LY3540378, Placebo
Eli Lilly and Company
Heart Failure, Heart Failure With Preserved Ejection Fraction
11/25
01/26

Download Options